UPDATE: Oppenheimer Upgrades Bed Bath & Beyond to Outperform, Raises PT on EPS Growth Potential

In a report published Thursday, Oppenheimer analyst Brian Nagel upgraded the rating on Bed Bath & Beyond BBBY from Perform to Outperform, and raised the price target from $71.00 to $92.00. In the report, Oppenheimer noted, “Bed Bath & Beyond represents, in our view, one of the best run and most dominant chains in Retail. Management has undertaken a number of strategic investments lately that have muddled near-term financials and limited EPS upside at the company. Q2 (Aug.) marks a turning point for BBBY whereby the chain begins to cycle past at least some of these investments. We are optimistic that as near-term pressures ease, the still solid underlying sales and EPS growth of BBBY will turn more apparent and investors will begin to award shares a higher multiple. We are lifting our rating on BBBY to Outperform. Our new $92 price target (up from $71) suggests upside of about 20% from current levels.” Bed Bath & Beyond closed on Wednesday at $75.94.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Analyst ColorUpgradesAnalyst RatingsBrian NagelOppenheimer
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!